• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Calcium channel antagonists: pharmacological considerations.

作者信息

Rampe D, Su C M, Yousif F, Triggle D J

出版信息

Br J Clin Pharmacol. 1985;20 Suppl 2(Suppl 2):247S-254S. doi: 10.1111/j.1365-2125.1985.tb02810.x.

DOI:10.1111/j.1365-2125.1985.tb02810.x
PMID:2996578
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1400653/
Abstract
摘要

相似文献

1
Calcium channel antagonists: pharmacological considerations.钙通道拮抗剂：药理学考量
Br J Clin Pharmacol. 1985;20 Suppl 2(Suppl 2):247S-254S. doi: 10.1111/j.1365-2125.1985.tb02810.x.
2
Calcium antagonists: review and perspective on mechanism of action.钙拮抗剂：作用机制的综述与展望
Am J Cardiol. 1989 Nov 7;64(17):3I-9I. doi: 10.1016/0002-9149(89)90955-7.
3
The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel.1,4-二氢吡啶受体：钙通道的一种调节成分。
J Cardiovasc Pharmacol. 1984;6 Suppl 7:S949-55.
4
[Molecular tools for the study of calcium channels: synthesis and evaluation of biological activity of new derivatives of 4-aryl-1,4-dihydropyridine groups].[用于研究钙通道的分子工具：4-芳基-1,4-二氢吡啶基团新衍生物的合成及生物活性评估]
Biokhimiia. 1988 Jul;53(7):1059-68.
5
Calcium-antagonist drugs. Receptor interactions that clarify therapeutic effects.
N Engl J Med. 1985 Oct 17;313(16):995-1002. doi: 10.1056/NEJM198510173131606.
6
[Research on receptors of calcium antagonists and the calcium channel].[钙拮抗剂的受体与钙通道研究]
Sheng Li Ke Xue Jin Zhan. 1988 Apr;19(2):155-60.
7
[Calcium channels: structure and function of receptors for calcium channel blockers in skeletal muscle].[钙通道：骨骼肌中钙通道阻滞剂受体的结构与功能]
Arzneimittelforschung. 1989 Jan;39(1A):164-8.
8
Calcium antagonist receptors. Clinical and physiological relevance.钙拮抗剂受体。临床及生理相关性。
Ann N Y Acad Sci. 1988;522:116-33. doi: 10.1111/j.1749-6632.1988.tb33349.x.
9
Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium.带电荷的二氢吡啶对L型钙通道的阻断。对应用侧和钙的敏感性。
J Gen Physiol. 1991 Jul;98(1):63-75. doi: 10.1085/jgp.98.1.63.
10
Regulation of cardiac L-type calcium current by phosphorylation and G proteins.磷酸化和G蛋白对心脏L型钙电流的调节
Annu Rev Physiol. 1990;52:257-74. doi: 10.1146/annurev.ph.52.030190.001353.

引用本文的文献

1
The Golgi Calcium ATPase Pump Plays an Essential Role in Adeno-associated Virus Trafficking and Transduction.高尔基钙 ATP 酶泵在腺相关病毒的运输和转导中起着至关重要的作用。
J Virol. 2020 Oct 14;94(21). doi: 10.1128/JVI.01604-20.
2
N-Salicyloyltryptamine, an N-Benzoyltryptamine Analogue, Induces Vasorelaxation through Activation of the NO/sGC Pathway and Reduction of Calcium Influx.N-水杨酰色胺，一种 N-苯甲酰色胺类似物，通过激活 NO/sGC 途径和减少钙内流诱导血管舒张。
Molecules. 2018 Jan 28;23(2):253. doi: 10.3390/molecules23020253.
3
Mechanisms of vasorelaxation induced by N-allylsecoboldine in rat thoracic aorta.N-烯丙基去甲紫堇碱诱导大鼠胸主动脉血管舒张的机制。
Naunyn Schmiedebergs Arch Pharmacol. 1994 Jun;349(6):637-43. doi: 10.1007/BF01258470.
4
Characterization of alpha 1-adrenoceptor subtypes in tension response of human prostate to electrical field stimulation.人前列腺对电场刺激的张力反应中α1-肾上腺素能受体亚型的特征分析
Br J Pharmacol. 1995 May;115(1):142-6. doi: 10.1111/j.1476-5381.1995.tb16331.x.
5
An examination of a possible pharmacokinetic interaction between nifedipine and antipyrine.硝苯地平和安替比林之间可能存在的药代动力学相互作用的研究。
Eur J Clin Pharmacol. 1990;39(4):405-7. doi: 10.1007/BF00315420.
6
Vasorelaxing effect in rat thoracic aorta caused by fraxinellone and dictamine isolated from the Chinese herb Dictamnus dasycarpus Turcz: comparison with cromakalim and Ca2+ channel blockers.从中药白鲜皮中分离得到的白鲜碱和吴茱萸碱对大鼠胸主动脉的血管舒张作用：与克罗卡林和钙通道阻滞剂的比较
Naunyn Schmiedebergs Arch Pharmacol. 1992 Mar;345(3):349-55. doi: 10.1007/BF00168697.

本文引用的文献

1
The selective inhibition of serotonin-induced contractions of rabbit cerebral vascular smooth muscle by calcium-antagonistic dihydropyridines. An investigation of the mechanism of action of nimodipine.钙拮抗二氢吡啶对兔脑血管平滑肌5-羟色胺诱导收缩的选择性抑制作用。尼莫地平作用机制的研究。
Circ Res. 1981 May;48(5):650-7. doi: 10.1161/01.res.48.5.650.
2
Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments.钙拮抗二氢吡啶衍生物尼莫地平在动物实验中的脑血管效应
Arzneimittelforschung. 1982;32(4):331-8.
3
Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).一种新型钙拮抗化合物——异丁基甲基 1,4 - 二氢 - 2,6 - 二甲基 - 4(2 - 硝基苯基)-3,5 - 吡啶二羧酸酯（尼索地平，Bay k 5552）的药理学
Arzneimittelforschung. 1980;30(12):2144-62.
4
Nisoldipine: a new, more selective calcium current blocker in cardiac Purkinje fibers.尼索地平：一种新型、对心脏浦肯野纤维更具选择性的钙电流阻滞剂。
J Pharmacol Exp Ther. 1982 Nov;223(2):446-56.
5
Sensitivity of cat papillary muscles to verapamil and nifedipine: enhanced effect in acidosis.猫乳头肌对维拉帕米和硝苯地平的敏感性：酸中毒时作用增强。
Cardiovasc Res. 1982 Apr;16(4):173-7. doi: 10.1093/cvr/16.4.173.
6
Response of forearm resistance vessels to verapamil and sodium nitroprusside in normotensive and hypertensive men: evidence for a functional abnormality of vascular smooth muscle in primary hypertension.
Clin Sci (Lond). 1982 Jul;63(1):33-42. doi: 10.1042/cs0630033.
7
Effect of calcium-antagonist and calmodulin-antagonist drugs on calmodulin-dependent contractions of chemically skinned vascular smooth muscle from rabbit renal arteries.钙拮抗剂和钙调蛋白拮抗剂药物对兔肾动脉化学去膜血管平滑肌钙调蛋白依赖性收缩的影响。
Naunyn Schmiedebergs Arch Pharmacol. 1983 Jun;323(2):85-9. doi: 10.1007/BF00634253.
8
Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.钙离子通道拮抗剂[3H]尼群地平与豚鼠回肠平滑肌结合的特性研究
J Pharmacol Exp Ther. 1983 May;225(2):291-309.
9
Comparison of calcium channel inhibitors on vagal heart rate responses elicited by arterial baroreceptor reflexes in anesthetized dogs.麻醉犬中钙通道抑制剂对动脉压力感受器反射引起的迷走性心率反应的比较。
J Pharmacol Exp Ther. 1984 Feb;228(2):491-9.
10
Cellular actions and pharmacology of the calcium channel blocking drugs.
Am J Med. 1984 Aug 31;77(2B):2-10.